Matuzumab (EMD 72000) is a humanized anti-EGFR activation and downstream signaling, inhibits tumor growth[1].
[1]. Joan H Schiller. Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000). Cancer Invest. 2008 Feb;26(1):81-95.
















